This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Inovio Pharmaceuticals Inc. shed 5.0% to $1.90 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.9% to 19,521.09 and Dow Jones Industrial Average falling 0.7% to 42,215.80.
Inovio Pharmaceuticals Inc. closed 84.6% below its 52-week high of $12.33, which the company achieved on July 26th.
The stock underperformed when compared to some of its competitors, as Johnson & Johnson fell 1.8% to $152.38, Statera Biopharma Inc. remained unchanged, and Pfizer Inc. fell 1.64% to $24.00.
Trading volume totaled 478,701, compared to the 50-day average of 603,105.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
June 17, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。